INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 411m ago
HOUSE PTR11m ago
SEC 13F11m ago
ROBINHOOD CHAIN11m ago
SEC FORM 4/Tax withholdingVerified data

Car Bruce reported BHVN

Chief Scientific Officer · Biohaven Ltd. · Common Shares

Side
F
Value
$24K
Shares
2,381
Price
$9.93
Executed
Jan 5, 2026
Disclosed
Jan 7, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Jan 5 executedJan 7, 2026 disclosed

BHVN · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
17/ 100 · ROUTINE
Methodology →
  • Transaction type0 / 20

    Tax withholding — administrative, little informational value

  • Relative size+9 / 25

$24K reported value · 44.6% of prior position

  • Filing timing0 / 15

    Disclosed 2 business days after execution (deadline: 2)

  • Historical behavior+8 / 15

    First recorded trade by this actor in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · BHVN

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    9
    AI
    Antonijevic IrinaDirector
    BHVNBiohaven Ltd.
    Grant or award
    		A—
    68.7K sh
    		Apr 28, 2026Apr 30, 2026
    traded Apr 28, 2026
    		+2dSEC FORM 4

    Evidence

    9
    MK
    Mehta KishanDirector
    BHVNBiohaven Ltd.
    Grant or award
    		A—
    68.7K sh
    		Apr 28, 2026Apr 30, 2026
    traded Apr 28, 2026
    		+2dSEC FORM 4

    Evidence

    12
    MK
    Mehta KishanDirector
    BHVNBiohaven Ltd.
    Gift
    		G—
    17.3K sh
    		Mar 17, 2026Mar 19, 2026
    traded Mar 17, 2026
    		+2dSEC FORM 4

    Evidence

    12
    MK
    Mehta KishanDirector
    BHVNBiohaven Ltd.
    Gift
    		G—
    17.3K sh
    		Mar 17, 2026Mar 19, 2026
    traded Mar 17, 2026
    		+2dSEC FORM 4

    Evidence

    9
    CC
    Clark George C.VP, Chief Accounting Officer
    BHVNBiohaven Ltd.
    Option exercise
    		M—
    2,500 sh
    		Jan 5, 2026Jan 7, 2026
    traded Jan 5, 2026
    		+2dSEC FORM 4

    Evidence

    9
    CC
    Clark George C.VP, Chief Accounting Officer
    BHVNBiohaven Ltd.
    Tax withholding
    		F$11K
    1,117 sh
    		Jan 5, 2026Jan 7, 2026
    traded Jan 5, 2026
    		+2dSEC FORM 4

    Evidence

    21
    CC
    Clark George C.VP, Chief Accounting Officer
    BHVNBiohaven Ltd.
    Option exercise
    		M—
    2,500 sh
    		Jan 5, 2026Jan 7, 2026
    traded Jan 5, 2026
    		+2dSEC FORM 4

    Evidence

    21
    CB
    Car BruceChief Scientific Officer
    BHVNBiohaven Ltd.
    Option exercise
    		M—
    4,750 sh
    		Jan 5, 2026Jan 7, 2026
    traded Jan 5, 2026
    		+2dSEC FORM 4

    Evidence

    9
    BM
    Buten MatthewChief Financial Officer
    BHVNBiohaven Ltd.
    Option exercise
    		M—
    4,250 sh
    		Jan 5, 2026Jan 7, 2026
    traded Jan 5, 2026
    		+2dSEC FORM 4

    Evidence

    9
    BM
    Buten MatthewChief Financial Officer
    BHVNBiohaven Ltd.
    Tax withholding
    		F$26K
    2,594 sh
    		Jan 5, 2026Jan 7, 2026
    traded Jan 5, 2026
    		+2dSEC FORM 4

    Evidence

    21
    BM
    Buten MatthewChief Financial Officer
    BHVNBiohaven Ltd.
    Option exercise
    		M—
    4,250 sh
    		Jan 5, 2026Jan 7, 2026
    traded Jan 5, 2026
    		+2dSEC FORM 4

    Evidence

    21
    CB
    Car BruceChief Scientific Officer
    BHVNBiohaven Ltd.
    Option exercise
    		M—
    4,750 sh
    		Jan 5, 2026Jan 7, 2026
    traded Jan 5, 2026
    		+2dSEC FORM 4

    Evidence

    46
    BG
    Bailey GregoryDirector
    BHVNBiohaven Ltd.
    Open-market purchase
    		BUY$3.00M
    400.0K sh
    		Nov 13, 2025Nov 17, 2025
    traded Nov 13, 2025
    		+4dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0001798876-26-000002
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    Jan 5, 2026
    Published
    Jan 7, 2026
    Ingested by INSIDER
    Nov 5, 04:24 UTC
    Last re-read
    Nov 5, 04:24 UTC

    Extracted facts

    Filer
    Car Bruce
    Role
    Chief Scientific Officer
    Transaction
    Tax withholdingAs filed: “F”
    Asset
    Biohaven Ltd.
    Ticker
    BHVN
    Shares
    2,381
    Price per share
    $9.93
    Value
    $23,643
    Execution date (reported)
    Jan 5, 2026
    Owned after transaction
    7,715 shares
    Days from execution to publication
    2

    Calculation

    Value = shares × reported price per share

    • Shares: 2,381
    • Price: $9.93

    = $23,643

    What this establishes

    Car Bruce filed this Form 4 reporting a tax withholding of BHVN on Jan 5, 2026. It became public on Jan 7, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    Chief Scientific Officer
    Car Brucecik:0001798876
    Issuer
    Biohaven Ltd.cik:0001935979

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.